Home › Lung Cancer › Pennsylvania › Reading
Lung Cancer clinical trials in Reading, PA
11 studies for Lung Cancer are looking for participants at sites in and around Reading (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Reading Hospital, West Reading · 1 mi away
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Penn State Health Saint Joseph Medical Center, Reading
- Reading Hospital, West Reading · 1 mi away
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
RecruitingPhase 3
- Reading Hospital, West Reading · 1 mi away
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecruitingPhase 3
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Reading Hospital, West Reading · 1 mi away
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 3
- Reading Hospital - McGlinn Cancer Institute, West Reading · 1 mi away
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer
RecruitingPhase 3
- Reading Hospital, West Reading · 1 mi away
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Ephrata Cancer Center, Ephrata · 17 mi away
- Sechler Family Cancer Center, Lebanon · 26 mi away
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
RecruitingObservational study
- US Digestive Health at Wyomissing, Wyomissing · 2 mi away
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Arlington, VA41 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Other studies in Reading
- Non-Small Cell Lung Cancer9 studies
- Acute Myeloid Leukemia5 studies
- Breast Cancer5 studies
- Disorders of Excessive Somnolence5 studies
- Prostate Cancer4 studies
- Cancer (all types)4 studies
- Colorectal Cancer3 studies
- Narcolepsy3 studies
- Sleep Disorders3 studies
- Fatigue3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.